NLRP3 and diabetic kidney disease: High glucose, AGEs, and ROS activate the NLRP3 inflammasome in podocytes, triggering canonical (caspase-1, IL-1β, IL-18) and non-canonical (autophagy regulation) pathways, contributing to sterile inflammation, podocyte dysfunction, and DKD progression.